Intellia Therapeutics Executive Salaries | Comparably
Intellia Therapeutics Claimed Company
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
170
HR or Marketing? Claim Your Free Employer Account

Intellia Therapeutics Executive Salaries

Key Executives

Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
John Leonard  CEO / President
CEO / President
-
-

The average Intellia Therapeutics executive compensation is $238,322 a year.The median estimated compensation for executives at Intellia Therapeutics including base salary and bonus is $245,229, or $117 per hour. At Intellia Therapeutics, the most compensated executive makes $575,750, annually, and the lowest compensated makes $61,000.

Last updated months ago.

$120k
$180k
$232k
$345k
$450k
$563k
$576k
$238,322*
Average Compensation
$245,229*
Median Compensation

* Estimated salaries Estimated salaries are based on data provided anonymously by employees and/or estimated by other statistical methods.

×
Rate your company